Pharmacist-Based Interventions for Health Behavior Change 2.0

A special issue of Pharmacy (ISSN 2226-4787). This special issue belongs to the section "Pharmacy Practice and Practice-Based Research".

Deadline for manuscript submissions: closed (30 November 2022) | Viewed by 4654

Special Issue Editors


E-Mail
Guest Editor
University of Tennessee Health Sciences Center, 301 S. Perimeter Park Drive, Nashville, TN 37211, USA
Interests: pharmacy operations; innovation and entrepreneurship; pharmacy workforce; pharmacy management
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
University of Tennessee Health Sciences Center, 301 S. Perimeter Park Drive, Nashville, TN 37211, USA
Interests: clinical pharmacy; program evaluation; epidemiology; public health; quantitative research; quantitative analytics; statistical modeling; survey design;
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The pharmacist’s role in promoting health behaviour change continues to grow. For instance, there is an increasing demand by stakeholders for pharmacist-led services that improve medication adherence; foster guideline-recommended vaccine administration; overcome vaccine resistance; and facilitate screening, interventions, and referrals for substance use disorders. As pharmacists continue to make the transition from focusing on products to focusing on patient care worldwide, their role in promoting health behaviour change is at the forefront. Moreover, their ease of accessibility in communities across the globe means that evidence-based interventions may be rapidly scaled. However, pharmacist training and scope of practice vary by country. Additionally, although there is a growing evidence base for these services, there is still much debate about the role of the pharmacist in services not directly tied to dispensing a product. This Special Issue of Pharmacy seeks current research related to pharmacist-based interventions for health behaviour change, including interventional studies investigating new or expanded behaviour change interventions, exploratory research suggesting potential new areas for these services, and dissemination and implementation studies focusing on the spread and scale of evidence-based health behaviour change interventions in pharmacy settings. For this Special Issue, we also welcome extended commentaries, reviews, and editorials grounded in peer-reviewed literature, as well as statements from professional and/or legislative bodies governing the practice of pharmacy at international, national, or more local/regional levels.

Dr. Kenneth C. Hohmeier
Dr. Justin Gatwood
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • health promotion
  • health behavior change
  • medication management services
  • implementation science
  • vaccines
  • tobacco cessation
  • substance use disorder

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Other

7 pages, 676 KiB  
Communication
Pharmacist-Led Implementation of Brief Tobacco Cessation Interventions during Mobile Health Access Events
by Karen Suchanek Hudmon, Julia S. Czarnik, Alexa M. Lahey, Susie J. Crowe, Megan Conklin, Robin L. Corelli, Jasmine D. Gonzalvo and Katy Ellis Hilts
Pharmacy 2023, 11(2), 72; https://doi.org/10.3390/pharmacy11020072 - 7 Apr 2023
Cited by 1 | Viewed by 2129
Abstract
To address gaps in care for individuals from under-resourced communities disproportionately affected by tobacco use, this pharmacist-led demonstration project evaluated the feasibility of implementing tobacco use screening and brief cessation interventions during mobile health access events. A brief tobacco use survey was administered [...] Read more.
To address gaps in care for individuals from under-resourced communities disproportionately affected by tobacco use, this pharmacist-led demonstration project evaluated the feasibility of implementing tobacco use screening and brief cessation interventions during mobile health access events. A brief tobacco use survey was administered verbally during events at two food pantries and one homeless shelter in Indiana to assess the interest and potential demand for tobacco cessation assistance. Individuals currently using tobacco were advised to quit, assessed for their readiness to quit, and, if interested, offered a tobacco quitline card. Data were logged prospectively, analyzed using descriptive statistics, and group differences were assessed by site type (pantry versus shelter). Across 11 events (7 at food pantries and 4 at the homeless shelter), 639 individuals were assessed for tobacco use (n = 552 at food pantries; n = 87 at the homeless shelter). Among these, 189 self-reported current use (29.6%); 23.7% at food pantries, and 66.7% at the homeless shelter (p < 0.0001). About half indicated readiness to quit within 2 months; of these, 9 out of 10 accepted a tobacco quitline card. The results suggest that pharmacist-led health events at sites serving populations that are under-resourced afford unique opportunities to interface with and provide brief interventions for people who use tobacco. Full article
(This article belongs to the Special Issue Pharmacist-Based Interventions for Health Behavior Change 2.0)
Show Figures

Figure 1

Other

Jump to: Research

9 pages, 4383 KiB  
Brief Report
Examining Routine Pediatric Vaccination Availability in Community Pharmacies in Washington State
by Kimberly Caye McKeirnan, Madison Shea Motzner and Sorosh Kherghehpoush
Pharmacy 2022, 10(6), 156; https://doi.org/10.3390/pharmacy10060156 - 22 Nov 2022
Cited by 3 | Viewed by 2022
Abstract
To address diminishing pediatric vaccination rates resulting from the COVID-19 pandemic, the Public Readiness and Emergency Preparedness (PREP) Act allows pharmacists, technicians, and pharmacy interns to administer any vaccine that the Advisory Committee on Immunization Practices (ACIP) guidelines recommend for all patients aged [...] Read more.
To address diminishing pediatric vaccination rates resulting from the COVID-19 pandemic, the Public Readiness and Emergency Preparedness (PREP) Act allows pharmacists, technicians, and pharmacy interns to administer any vaccine that the Advisory Committee on Immunization Practices (ACIP) guidelines recommend for all patients aged 3 years and older. A survey was conducted to evaluate the role of pharmacy personnel in the community setting providing immunizations for the pediatric patients. Sixty-seven pharmacies were contacted in a state where pharmacists are allowed to administer vaccinations to any patient over the age of six months. Of the 58 respondent pharmacies offering vaccinations for pediatric patients, the most commonly reported vaccines included influenza (97%), tetanus, diphtheria, and pertussis (88%), hepatitis (71%), human papillomavirus (69%), meningococcal vaccines (66%), polio (45%), and Haemophilus influenzae type b vaccine (40%). Nearly all respondent pharmacies (56/58) reported having at least one of the ACIP-recommended routine childhood vaccinations available for patients under the age of 18. Community pharmacies are well-positioned to administer routine vaccinations to pediatric patients and address declining pediatric vaccination rates. Full article
(This article belongs to the Special Issue Pharmacist-Based Interventions for Health Behavior Change 2.0)
Show Figures

Figure 1

Back to TopTop